Emergent Biosolutions
EBS
EBS
205 hedge funds and large institutions have $1.29B invested in Emergent Biosolutions in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 81 increasing their positions, 69 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
205
Holders Change
+6
Holders Change %
+3.02%
% of All Funds
5.38%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.11%
New
32
Increased
81
Reduced
69
Closed
24
Calls
$545K
Puts
$1.24M
Net Calls
-$695K
Net Calls Change
-$699K
Top Buyers
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
$26.9M |
| 2 |
Bank of New York Mellon
New York
|
$74.3M |
| 3 |
State Street
Boston,
Massachusetts
|
$35.7M |
| 4 |
KCM
Kingdon Capital Management
New York
|
$4.81M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
$17M |
